Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial

alexandrossfakianakis shared this article with you from Inoreader Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial Via ScienceDirect Publication: The Lancet Infectious Diseases Publication date: Available online 6 May 2022 Source: The Lancet Infectious Diseases Author(s): Moses Laman, Livingstone Tavul, Stephan Karl, Bethuel Kotty, Zebede Kerry, Stephen Kumai, Anna Samuel, Lina Lorry, Lincoln Timinao, S Cade Howard, Leo Makita, Lucy John, Sibauk Bieb, James Wangi, Jeffrey M Albert, Michael Payne, Gary J Weil, Daniel J Tisch, Catherine M Bjerum, Leanne J Robinson View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.